The healthcare sector has witnessed significant fluctuations over recent times, affecting major stocks differently across various durations. While some firms showed resilience, others struggled, reflecting broader market and sector-specific trends. Investors seeking diversification within this sector may find themselves needing a strategic re-evaluation based on these recent performances. 📊
| Stock | Performance (%) | Performance |
|---|---|---|
| ISRG | 3.70 | |
| AMGN | 1.53 | |
| TMO | 1.24 | |
| MRK | 0.69 | |
| JNJ | -0.38 | |
| ABT | -0.40 | |
| UNH | -1.09 | |
| ABBV | -2.89 | |
| LLY | -2.96 |
| Stock | Performance (%) | Performance |
|---|---|---|
| MRK | 12.46 | |
| JNJ | 9.76 | |
| AMGN | 8.94 | |
| ABT | 4.52 | |
| ABBV | 2.75 | |
| ISRG | -3.62 | |
| LLY | -4.20 | |
| UNH | -18.04 | |
| TMO | -19.96 |
| Stock | Performance (%) | Performance |
|---|---|---|
| MRK | 20.43 | |
| JNJ | 16.64 | |
| AMGN | 12.55 | |
| ABBV | -1.31 | |
| LLY | -4.03 | |
| UNH | -6.46 | |
| ISRG | -11.39 | |
| ABT | -11.67 | |
| TMO | -13.04 |
Across different timeframes, the healthcare sector has shown marked divergence among individual stocks. Notably, Merck (MRK) has consistently outperformed over the three observed periods, particularly in the one-month and three-month horizons. Conversely, Thermo Fisher Scientific (TMO) and UnitedHealth Group (UNH) have faced significant declines, affected by both broader market conditions and sector-specific headwinds. This period highlights the necessity for prudent selection and diversification, given the sector's mixed performance. Investors should consider these historical performances when strategizing their portfolios, taking into account both the opportunities and risks inherent in the healthcare landscape. ⚠️
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.